Altimmune Inc (ALT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mack Gill
Employees:
27
19 FIRSTFIELD ROAD, GAITHERSBURG, MD 20878
2406541450

PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Data derived from most recent annual or quarterly report
Market Cap 216.978 Million Shares Outstanding43.223 Million Avg 30-day Volume 732.199 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue74.2918 Debt to Equity0.0323 EBITDA-104.947 Million
Price to Book Value1.4485 Operating Margin-2817.4809 Enterprise Value93.771 Million
Current Ratio9.992 EPS Growth0 Quick Ratio9.42
1 Yr BETA 1.4461 52-week High/Low 19.46 / 3.83 Profit Margin-2820.388
Operating Cash Flow Growth-45.7676 Altman Z-Score4.9267 Free Cash Flow to Firm -60.336 Million
Earnings Report2022-08-09
View SEC Filings from ALT instead.

View recent insider trading info

Altimmune Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ALT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GARG VIPIN K PRESIDENT AND CEO

  • Officer
  • Director
 283,826 2022-04-30 13

HARRIS MATTHEW SCOTT CHIEF MEDICAL OFFICER

  • Officer
 42,945 2022-02-28 3

ROBERTS M SCOT CHIEF SCIENTIFIC OFFICER

  • Officer
 172,630 2022-01-31 2

DRUTZ DAVID

  • Director
 18,284 2022-01-25 5

GILL JOHN

  • Director
 2,771 2021-12-31 2

EISENSTADT RICHARD I CHIEF FINANCIAL OFFICER

  • Officer
 0 2021-12-31 2

SAYARE MITCHEL

  • Director
 24,100 2021-09-23 1

JORKASKY DIANE

  • Director
 24,100 2021-09-23 1

HODGES PHILIP

  • Director
 24,100 2021-09-23 1

SCHAFER KLAUS

  • Director
 24,100 2021-09-23 1

PISANO WAYNE

  • Director
 24,100 2021-09-23 1

BROWN WILLIAM MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
 17,721 2021-07-31 1

VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

VHCP CO-INVESTMENT HOLDINGS III, LLC

VHCP MANAGEMENT III, LLC

VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

VHCP CO-INVESTMENT HOLDINGS II, LLC

VHCP MANAGEMENT II, LLC

KOH BONG Y

SHAH NIMISH P

  • 10% Owner
 No longer subject to file 2021-02-25 0

VELOCITY PHARMACEUTICAL HOLDINGS LLC

  • 10% Owner
 No longer subject to file 2020-05-14 0

VELOCITY PHARMACEUTICAL HOLDINGS LLC

COLLIER DAVID J

WATSON JAMES F

VELOCITY PHARMA MANAGEMENT, LLC

  • 10% Owner
 1,887,250 2019-07-12 0

TASKER SYBIL CHIEF MEDICAL OFFICER

  • Officer
 0 2019-06-17 0

NOVARTIS BIOVENTURES LTD

NOVARTIS AG

  • 10% Owner
 No longer subject to file 2018-10-02 0

ENRIGHT WILLIAM PRESIDENT AND CEO

  • Officer
  • Director
 365,839 2018-05-25 0

TRUFFLE CAPITAL S.A.S.

  • 10% Owner
 2,161,802 2018-02-13 0

SCHAFFER DERACE L

  • Director
 1,152,600 2017-12-28 0

HODGES PHILIP

REDMONT VAXN CAPITAL HOLDINGS, LLC

  • Director
 0 2017-10-13 1

CZEREPAK ELIZABETH CFO AND EVP CORP. DEVELOPMENT

  • Officer
 0 2017-09-22 0

HODGES PHILIP

REDMONT VAXN CAPITAL HOLDINGS, LLC

PARADIGM VENTURE PARTNERS, L.P.

REDMONT VENTURE PARTNERS, INC.

  • Director
  • 10% Owner
 0 2017-05-04 0

RUNGE JEFFREY W.

  • Director
 197,700 2017-01-20 0

ST PETER STEVEN

  • Director
 205,004 2017-01-04 0

MACNEILL PHILIP VP, CFO, TREASURER, SECRETARY

  • Officer
 126,346 2016-12-21 0

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

FROHLICH PHIL

  • 10% Owner
 No longer subject to file 2016-12-07 0

RICHMAN ERIC I

  • Director
 908,055 2016-11-22 0

JONES JEFFREY MICHAEL COO

  • Officer
 2,544 2015-03-11 0

CHANG LINDA L SVP, CFO & SECRETARY

  • Officer
 30,000 2015-01-07 0

MARKISON BRIAN A

  • Director
 0 2014-12-31 0

MCCLEARY JOEL

  • Director
 0 2014-12-31 0

COOK FRANCESCA M SVP, POLICY & GOV'T AFFAIRS

  • Officer
 0 2014-12-08 0

MORGES WAYNE SVP, REG. AFFAIRS & QUALITY

  • Officer
 0 2014-12-08 0

KARP JORDAN P SVP, GENERAL COUNSEL

  • Officer
 0 2012-12-03 0

FUERST THOMAS RICHARD EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2011-12-01 0

PAPPAJOHN JOHN

  • Director
 0 2011-06-23 0

RIDDLE VALERIE D SVP, MEDICAL DIRECTOR

  • Officer
 44,436 2011-05-25 0

REINHART CHARLES A. III SVP, CHIEF FINANCIAL OFFICER

  • Officer
 0 2010-12-08 0

HEALTHCARE VENTURES VII LP

LAWLOR AUGUSTINE

LITTLECHILD JOHN W

MIRABELLI CHRISTOPHER

WERNER HAROLD R

CAVANAUGH JAMES H

HEALTHCARE PARTNERS VII, L.P.

  • Director
  • 10% Owner
 4,253,057 2010-11-03 0

EVNIN LUKE

GALAKATOS NICHOLAS

HENNER DENNIS

STEINMETZ MICHAEL

GADICKE ANSBERT

WHEELER KURT

SIMON NICHOLAS J III

  • 10% Owner
 12,265,228 2010-11-03 0

MPM BIOVENTURES III LLC

MPM BIOVENTURES III PARALLEL FUND, L.P.

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III L.P.

MPM BIOVENTURES III GP L.P.

MPM BIOVENTURES III-QP L.P.

MPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLC

  • 10% Owner
 12,265,228 2010-11-03 0

CAVANAUGH JAMES H

  • Director
  • 10% Owner
 0 2010-06-23 0

FUSCO JOAN SVP, OPERATIONS

  • Officer
 0 2010-05-06 0

CAMUT CHRISTOPHER C VP, GOV'T CONTRACTS

  • Officer
 No longer subject to file 2010-01-21 0

WRIGHT DAVID P PRESIDENT AND CEO

  • Officer
  • Director
 399,500 2009-12-11 0

PRICE KEVIN PRESIDENT - PHARMATHENE UK,LTD

  • Officer
 0 2009-01-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GARG VIPIN K - Director - Officer PRESIDENT AND CEO

2022-05-02 19:00:41 -0400 2022-04-30 F 3,008 $4.52 d 283,826 direct -1.6842 -10.1053 0.0 1 -12.6316 5

GARG VIPIN K - Director - Officer PRESIDENT AND CEO

2022-03-31 19:00:37 -0400 2022-03-30 F 3,007 $6.05 d 286,834 direct 1.7685 -8.6817 -22.6688 1.7685 2 -36.6559 28

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALTIMMUNE INC ALT 2022-05-20 22:15:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 21:45:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 21:15:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 20:45:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 20:15:05 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 19:45:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 19:15:04 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 18:45:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 18:15:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 17:45:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 17:15:03 UTC -0.1827 1.0027 2500000
ALTIMMUNE INC ALT 2022-05-20 16:45:04 UTC -0.1857 1.0057 2500000
ALTIMMUNE INC ALT 2022-05-20 16:15:03 UTC -0.1857 1.0057 2500000
ALTIMMUNE INC ALT 2022-05-20 15:45:03 UTC -0.1857 1.0057 2500000
ALTIMMUNE INC ALT 2022-05-20 15:15:03 UTC -0.1857 1.0057 2500000
ALTIMMUNE INC ALT 2022-05-20 14:45:03 UTC -0.1854 1.0054 2500000
ALTIMMUNE INC ALT 2022-05-20 14:15:04 UTC -0.1854 1.0054 2500000
ALTIMMUNE INC ALT 2022-05-20 13:45:03 UTC -0.1854 1.0054 2500000
ALTIMMUNE INC ALT 2022-05-20 13:15:03 UTC -0.1854 1.0054 2300000
ALTIMMUNE INC ALT 2022-05-20 12:45:03 UTC -0.1854 1.0054 2300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments